Abstract

GPR81 is an orphan G protein-coupled receptor (GPCR) that has a high degree of homology to the nicotinic acid receptor GPR109A. GPR81 expression is highly enriched and specific in adipocytes. However, the function and signaling properties of GPR81 are unknown because of the lack of natural or synthetic ligands. Using chimeric G proteins that convert Gi-coupled receptors to Gq-mediated inositol phosphate (IP) accumulation, we show that GPR81 can constitutively increase IP accumulation in HEK293 cells and suggest that GPR81 couples to the Gi signaling pathway. We also constructed a chimeric receptor that expresses the extracellular domains of cysteinyl leukotriene 2 receptor (CysLT2R) and the intracellular domains of GPR81. We show that the CysLT2R ligand, leukotriene D(4) (LTD4), is able to activate this chimeric receptor through activation of the Gi pathway. In addition, LTD4 is able to inhibit lipolysis in adipocytes expressing this chimeric receptor. These results suggest that GPR81 couples to the Gi signaling pathway and that activation of the receptor may regulate adipocyte function and metabolism. Hence, targeting GPR81 may lead to the development of a novel and effective therapy for dyslipidemia and a better side effect profile than nicotinic acid.

Highlights

  • GPR81 is an orphan G protein-coupled receptor (GPCR) that has a high degree of homology to the nicotinic acid receptor GPR109A

  • We show that activation of our chimeric receptor by leukotriene D4 (LTD4) results in the inhibition of lipolysis in adipocytes

  • The primers used for GPR81 were 5¶-TCTTCCTGCCCCTGACAATC-3¶, 5¶-CCGTCTCAGGCTCCAAACA-3¶, and 5¶-6FAM-TCTTGTTCTGCTCGGTCAACG-BHQ1-3¶; the primers for cysteinyl leukotriene 2 receptor (CysLT2R)/GPR81 were 5¶-CAACCATCCATCTCCGTATCAG3¶, 5¶-TTGTGCAGTTCCTGCTGTTGT-3¶, and 5¶-6FAM-AATGGAACCAAATGGCACCTTCAGCAAT-BHQ1-3¶; the primers for GPR109A were from ABI; and the primers for GAPDH were from ABI

Read more

Summary

MATERIALS AND METHODS

GPR81 expression in tissues and differentiated adipocytes was analyzed using quantitative PCR. Mouse RNA was from Ambion FirstChoice Total RNA: Mouse Normal Tissue Survey Panel (catalog No AM7800). Mouse 3T3-L1 preadipocytes were cultured and differentiated into adipocytes as described previously [14]. The primers used for GPR81 were 5¶-TCTTCCTGCCCCTGACAATC-3¶, 5¶-CCGTCTCAGGCTCCAAACA-3¶, and 5¶-6FAM-TCTTGTTCTGCTCGGTCAACG-BHQ1-3¶; the primers for CysLT2R/GPR81 were 5¶-CAACCATCCATCTCCGTATCAG3¶, 5¶-TTGTGCAGTTCCTGCTGTTGT-3¶, and 5¶-6FAM-AATGGAACCAAATGGCACCTTCAGCAAT-BHQ1-3¶; the primers for GPR109A were from ABI (catalog No Mm02620500 s1); and the primers for GAPDH were from ABI (catalog No 4352932E). Quantitative PCR was performed on Stratagene Mx3000P quantitative PCR machines with the Stratagene Brilliant QRT-PCR Master Mix Kit, 1-Step (catalog No 600551) using 100 ng RNA/ well and normalized with mouse GAPDH (ABI)

Inositol phosphate accumulation assay
Aequorin assay
Transgenic animal preparations
Preparation of mouse primary adipocytes and lipolysis assay
RESULTS AND DISCUSSIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call